Project
A Phase 1/2 Study of BMS-986408 Alone and in Combination with Nivolumab or with Nivolumab and Ipilimumab in Participants with Advanced Solid Tumors
Ongoing - recruitment active · 2023 until 2030
Jörger Markus, Hutter Franziska
Project
Ongoing - recruitment active · 2023 until 2030
Jörger Markus, Hutter Franziska